Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Conditions: Oral Cancer, Pharynx Cancer, Sleep Apnea, Snoring, Oral Squamous Cell Carcinoma

Sex: All

Ages: 18 Years – 65 Years

Phase: NA

Enrollment: 35

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Summary

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

Eligibility Criteria

Inclusion Criteria:oropharyngeal cancer diagnosis18 years of age and overfemale or male; ratio of 1/4 toward menhad received RTH in the Department of Radiation Oncology,reporting snoring and/or respiratory cessation complaints during sleep,Exclusion Criteria:pregnant or breastfeeding woman;edentation preventing retention of the oral appliance;taking opioid or anxiolitic type medications;history of major depression,uncontrolled hypertension,history of stroke;under treatment with CPAP for sleep apnea;regular and intense orofacial pain;under pharmacological treatment for insomnia;excessive alcohol or drug use (e.g., cannabis, opioid).

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05719779). StuddyBuddy aggregates publicly available trial information.